Janus kinase inhibitors in the management of lichen planus: a systematic review. (PubMed, Ann Med) - Oct 8, 2026 - "There were 13 papers on tofacitinib, six on baricitinib, and two papers each on ruxolitinib and upadacitinib. Several case series and case reports have shown beneficial effects of JAK inhibitors to treat LP. Few patients had minor adverse events."
Journal • Review • Alopecia • Atopic Dermatitis • Dermatitis • Dermatology • Dermatopathology • Immunology • Inflammation • Lichen Planus
|
|
Abeer G Almutairi; Asem Shadid; Atheer G Almutairi; Azzam Alkhalifah; Houriah Nukaly; Leena I Aloraini; Saleha Khan
|